Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-101314
Filing Date
2025-10-21
Accepted
2025-10-21 17:30:18
Documents
1
Period of Report
2025-10-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2529035-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2529035-1_4seq1.xml 4 12412
  Complete submission text file 0001104659-25-101314.txt   14643
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PHIBRO ANIMAL HEALTH CORP 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666
Business Address
BENDHEIM JACK (Reporting) CIK: 0001241560 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 251408065

Mailing Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666
Business Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 2013297300
BFI Co., LLC (Reporting) CIK: 0001601607 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 251408064